| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.00052 | 1 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.00036 | 1 |